HighPoint Advisor Group’s Alpine Immune Sciences Inc ALPN Stock Holding History

HighPoint Advisor Group’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,567	Closed	-$621K	–	645
2024 Q1	$621K	Sell	9,567 -5,623	-37%	-$166K	0.04%	310
2023 Q4	$570K	Buy	+15,190	New	+$211K	0.04%	331

HighPoint Advisor Group's ALPN Position: Q2 2024 in Review

HighPoint Advisor Group sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 9,567 shares — an estimated $621K sold.

HighPoint Advisor Group first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $621K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

HighPoint Advisor Group reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
HighPoint Advisor Group sold 9,567 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $621K.
HighPoint Advisor Group first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
HighPoint Advisor Group's Alpine Immune Sciences Inc position peaked at $621K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on HighPoint Advisor Group's 13F filing for Q2 2024, filed 8 Aug 2024.